REG - Halma PLC - Annual Financial Report

HalmaAnnouncement

20/06/2025 17:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250620:nRST8472Na&default-theme=true

RNS Number : 8472N  Halma PLC  20 June 2025

Halma plc

 

Annual Report and Accounts 2025 and Notice of Annual General Meeting

 

Halma announces that the Annual Report and Accounts 2025 and the Notice of
Meeting have been posted to shareholders (where applicable) and, in accordance
with Disclosure Guidance and Transparency Rule 6.3.5(3)R, are available to
view on the Company's website at www.halma.com.

 

Copies of these documents and the Proxy Form have been submitted to the
National Storage Mechanism and will shortly be available for inspection
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

The Full Year Results, containing information required under Disclosure
Guidance and Transparency Rule 6.3.5R were released on 12 June 2025 and are
also available on the Company's website.

 

 For further information, please contact:

 Mark Jenkins

 Company Secretary, Halma plc

 Tel: +44 (0)1494 721111

 

NOTE TO EDITORS

 

Halma is a global group of life-saving technology companies, focused on
growing a safer, cleaner, healthier future for everyone, every day. Its
purpose defines the three market areas where it operates:

 

 ·      Safety                              Protecting people, assets and infrastructure in commercial, industrial and
                                            public spaces. Reducing safety risks in hazardous situations, increasing
                                            efficiency and helping to create a more sustainable future.

 ·      Environmental & Analysis            Monitoring and protecting the environment, and ensuring the quality and
                                            availability of life‑critical resources. Creating solutions used in
                                            materials analysis and optoelectronic applications.

 ·      Healthcare                          Improving the care delivered by healthcare providers, and enhancing the

                                          quality of patients' lives, through contributing to the discovery and
                                            development of new cures, the diagnosis and treatment of patient conditions,

                                          and data analysis.

 

Halma employs over 9,000 people in more than 20 countries, with major
operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is
listed on the London Stock Exchange (LON: HLMA) and is a constituent of the
FTSE 100 index.

 

Halma has been named one of Britain's Most Admired Companies for the past six
years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSPKKBDABKDDAB